Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Headquarters
460 Totten Pond Road
Suite 650
Waltham, MA, 02451
USA

People

CEO
President
Member of Board
Board Chairman

Funding

TOTAL $37.3M
FUNDING TOTAL $37.3M
Series A, 3/2010
Domain Associates
MPM Capital
Avalon Ventures
Forward Ventures
Pappas Ventures
$9M
Series B, 8/2013
Domain Associates
RusnanoMedInvest
MPM Capital
Forward Ventures
$26.6M
Venture Round, 2/2014
$1.73M
DEBT TOTAL $6.01M
Debt, 4/2010
$6.01M

Tags

Syndax Pharmaceuticals

Syndax Pharmaceuticals specializes is a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors

Recent Milestones

Videos

Screenshots

Syndax Pharmaceuticals screenshot
Above: Home Page
Uploaded: 3/18/10

Sources

  1. Syndax Pharmaceuticals, Inc.: Series A $9M (onbiovc.com) [edit]
  2. SEC (sec.gov) [edit]
  3. Syndax Pharmaceuticals Secures $26.6M Series B Financing (finsmes.com) [edit]
  4. SEC (sec.gov) [edit]
Edit This Page
Last Edited 4/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy